Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

TUNKHANNOCK HOSPITAL COMPANY LLC

NPI: 1518256726 · TUNKHANNOCK, PA 18657 · Ambulatory Surgical Clinic/Center · NPI assigned 03/29/2011

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more

$275K
Total Medicaid Paid
13,239
Total Claims
12,398
Beneficiaries
52
Codes Billed
2020-02
First Month
2021-09
Last Month

Provider Details

Authorized OfficialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
NPI Enumeration Date03/29/2011

Related Entities

Other providers sharing the same authorized official: LALOR, PAULA

ProviderCityStateTotal Paid
ROSWELL HOSPITAL CORPORATION ROSWELL NM $41.27M
WESLEY HEALTH SYSTEM LLC HATTIESBURG MS $37.82M
METRO KNOXVILLE HMA LLC POWELL TN $28.70M
BULLHEAD CITY HOSPITAL CORPORATION BULLHEAD CITY AZ $28.54M
IOM HEALTH SYSTEM LP FORT WAYNE IN $27.50M
ST. JOSEPH HEALTH SYSTEM, LLC FORT WAYNE IN $25.43M
LAREDO TEXAS HOSPITAL COMPANY LP LAREDO TX $19.46M
OAK HILL HOSPITAL CORPORATION OAK HILL WV $18.77M
COCKE COUNTY HMA, LLC NEWPORT TN $18.34M
CLEVELAND TENNESSEE HOSPITAL COMPANY LLC CLEVELAND TN $16.31M
JEFFERSON COUNTY HMA LLC JEFFERSON CITY TN $14.31M
NORTHWEST ARKANSAS HOSPITALS, LLC SPRINGDALE AR $11.46M
PETERSBURG HOSPITAL COMPANY LLC PETERSBURG VA $11.20M
CAMPBELL COUNTY HMA, LLC LAFOLLETTE TN $10.07M
WARSAW HEALTH SYSTEM LLC WARSAW IN $9.95M
LONGVIEW MEDICAL CENTER LP LONGVIEW TX $9.29M
MOBERLY HOSPITAL COMPANY LLC MOBERLY MO $8.61M
CRESTVIEW HOSPITAL COMPANY, LLC CRESTVIEW FL $8.15M
KIRKSVILLE MISSOURI HOSPITAL COMPANY, LLC KIRKSVILLE MO $7.98M
VICTORIA OF TEXAS LP VICTORIA TX $7.74M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 2,405 $55K
2021 10,834 $220K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 676 637 $54K
99283 Emergency department visit for the evaluation and management, moderate severity 929 885 $49K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 760 731 $24K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 191 184 $20K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 162 162 $13K
80053 Comprehensive metabolic panel 1,254 1,175 $12K
99281 Emergency department visit for the evaluation and management, self-limited or minor 304 299 $9K
99282 Emergency department visit for the evaluation and management, low to moderate severity 209 201 $7K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 281 266 $7K
70450 Computed tomography, head or brain; without contrast material 117 112 $7K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1,333 1,221 $7K
84443 Thyroid stimulating hormone (TSH) 308 303 $7K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 476 461 $5K
74177 Computed tomography, abdomen and pelvis; with contrast material 30 30 $5K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 530 486 $4K
74176 Computed tomography, abdomen and pelvis; without contrast material 41 40 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 60 57 $4K
96375 Therapeutic injection; each additional sequential IV push 195 182 $3K
96361 Intravenous infusion, hydration; each additional hour 212 199 $3K
71046 Radiologic examination, chest; 2 views 212 209 $3K
80061 Lipid panel 214 213 $3K
84703 237 227 $2K
80048 Basic metabolic panel (calcium, ionized) 274 243 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 169 157 $2K
84484 273 235 $2K
71045 Radiologic examination, chest; single view 240 231 $2K
80305 119 115 $1K
83690 291 270 $1K
87086 Culture, bacterial; quantitative colony count, urine 175 168 $1K
81001 476 442 $1K
84439 162 160 $1K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 24 24 $940.79
85027 148 143 $933.00
85610 298 260 $905.44
87040 68 37 $768.60
86618 31 31 $743.92
83036 Hemoglobin; glycosylated (A1C) 99 99 $621.46
36415 Collection of venous blood by venipuncture 499 426 $568.00
83735 86 83 $530.05
83605 67 57 $461.20
85651 159 154 $428.39
84481 14 14 $309.56
J1885 Injection, ketorolac tromethamine, per 15 mg 248 215 $188.54
86140 64 61 $177.60
82150 41 40 $177.25
73610 12 12 $161.03
73630 12 12 $106.86
85378 12 12 $92.67
J2405 Injection, ondansetron hydrochloride, per 1 mg 205 186 $88.31
J2704 Injection, propofol, 10 mg 25 24 $30.10
J7030 Infusion, normal saline solution , 1000 cc 181 171 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 36 36 $0.00